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One Sentence Summary: Comprehensive heritability analysis of brain phenotypes demonstrates a 58 
clear role for common genetic variation across neurological and psychiatric disorders and 59 
behavioral-cognitive traits, with substantial overlaps in genetic risk. 60 
Abstract: Disorders of the brain exhibit considerable epidemiological comorbidity and frequently share 61 
symptoms, provoking debate about the extent of their etiologic overlap. We quantified the genetic sharing 62 
of 25 brain disorders based on summary statistics from genome-wide association studies of 215,683 63 
patients and 657,164 controls, and their relationship to 17 phenotypes from 1,191,588 individuals. 64 
Psychiatric disorders show substantial sharing of common variant risk, while neurological disorders 65 
appear more distinct from one another. We observe limited evidence of sharing between neurological and 66 
psychiatric disorders, but do identify robust sharing between disorders and several cognitive measures, as 67 
well as disorders and personality types. We also performed extensive simulations to explore how power, 68 
diagnostic misclassification and phenotypic heterogeneity affect genetic correlations. These results 69 
highlight the importance of common genetic variation as a source of risk for brain disorders and the value 70 
of heritability-based methods in understanding their etiology. 71 
The classification of brain disorders has evolved over the past century, reflecting the 72 
medical and scientific communities’ best assessments of the presumed root causes of clinical 73 
phenomena such as behavioral change, loss of motor function, spontaneous movements or 74 
alterations of consciousness. A division between neurology and psychiatry developed, with the 75 
more directly observable phenomena (such as the presence of emboli, protein tangles, or unusual 76 
electrical activity patterns) generally defining the neurological disorders(1). Applying modern 77 
methods to understand the genetic underpinnings and categorical distinctions between brain 78 
disorders may be helpful in informing next steps in the search for the biological pathways 79 
underlying their pathophysiology(2, 3). 80 
In general, brain disorders (here excepting those caused by trauma, infection or cancer) 81 
show substantial heritability from twin and family studies (4). Epidemiological and twin studies 82 
have explored patterns of phenotypic overlaps(5-7), and substantial comorbidity has been 83 
reported for many pairs of disorders, including bipolar disorder-migraine(8), stroke-major 84 
depressive disorder(MDD)(9), epilepsy-autism spectrum disorders (ASD) and epilepsy-attention 85 
deficit hyperactivity disorder (ADHD)(10, 11). Furthermore, neurological and psychiatric 86 
research has shown that mutations in the same ion channel genes confer pleiotropic risk for 87 
multiple distinct brain phenotypes(12-14). Recently, genome-wide association studies (GWAS) 88 
have demonstrated that individual common risk variants show overlap across traditional 89 
diagnostic boundaries (15, 16), and that disorders like schizophrenia, MDD and bipolar disorder 90 
can have strong genetic correlations(17).  91 
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GWAS have also demonstrated that common genetic variation substantially contributes 92 
to the heritability of brain disorders. In most cases, this occurs via many common variants, each 93 
of small effect, with examples in Alzheimer’s disease(18), bipolar disorder(19), migraine(20), 94 
Parkinson’s disease(21), and schizophrenia(22). In addition to locus discovery, the degree of 95 
distinctiveness (23) across a wide set of neurological and psychiatric phenotypes can now be 96 
evaluated with the introduction of novel heritability-based methods(24) and sufficiently large 97 
sample sizes. These analyses can shed light on the nature of these diagnostic boundaries and 98 
explore the extent of shared common variant genetic influences.  99 
 100 
Study design 101 
We formed the Brainstorm consortium, a collaboration among GWAS meta-analysis 102 
consortia of 25 disorders (see Data sources), to perform the first comprehensive heritability and 103 
correlation analysis of brain disorders. We included all common brain disorders for which we 104 
could identify a GWAS meta-analysis consortium of sufficient size for heritability analysis that 105 
was willing to participate. The total study sample consists of 215,683 cases of different brain 106 
disorders and 657,164 controls (Table 1), and provides coverage of a majority of ICD-10 blocks 107 
covering mental and behavioral disorders and diseases of the central nervous system. Also 108 
included are 1,191,588 samples for 13 “behavioral-cognitive” phenotypes (n=744,486) chosen 109 
for being traditionally viewed as brain-related, and four “additional” phenotypes (n=447,102) 110 
selected to represent known, well-delineated etiological processes (e.g. immune disorders 111 
[Crohn’s disease] and vascular disease [coronary artery disease]; Table 2) or anthropomorphic 112 
measures (height and BMI).  113 
GWAS summary statistics for the 42 disorders and phenotypes were centralized and 114 
underwent uniform quality control and processing(25). Where necessary, we generated 115 
European-only meta-analyses for each disorder to avoid potential biases arising from ancestry 116 
differences, as many of the brain disorder datasets included sample sets from diverse ancestries. 117 
Clinically relevant subtypes from three disorders (epilepsy, migraine and ischemic stroke) were 118 
also included; in these cases, the analyzed datasets are subsets of the top-level dataset, as shown 119 
in Table 1.  120 
We have recently developed a novel heritability estimation method, linkage 121 
disequilibrium score regression (LDSC)(24), which was used to calculate heritability estimates 122 
and correlations, as well as to estimate their statistical significance from block jack-knife-based 123 
standard errors. Heritability for binary disorders and phenotypes was transformed to the liability-124 
scale. We further performed a weighted-least squares regression analysis to evaluate whether 125 
differences relating to study makeup (such as sample size) were correlated with the magnitude of 126 
the correlation estimates. We also performed a heritability partitioning analysis using stratified 127 
LD score regression to examine whether the observed heritability was enriched in any tissue-128 
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specific regulatory partitions of the genome, using the ten top-level tissue-type and 53 functional 129 
partitions from Finucane et al. (26). Finally, simulated phenotype data was generated under 130 
several different scenarios by permuting the 120,267 genotyped individuals from the UK 131 
Biobank (25) to both evaluate power and aid in interpreting the results (see Supplementary Text). 132 
 133 
Heritability and correlations among brain disorders 134 
We observed a similar range of heritability estimates among the disorders and the 135 
behavioral-cognitive phenotypes (Fig. S1A-B and Table S1, S2), roughly in line with previously 136 
reported estimates obtained from smaller datasets (see Table S3 and Supplementary Text). Three 137 
ischemic stroke subtypes (cardioembolic, large-vessel disease and small-vessel disease) as well 138 
as the “agreeableness” personality measure from NEO Five-Factor Inventory(27) had insufficient 139 
evidence of additive heritability for robust analysis and thus were excluded from further 140 
analysis(25). We did not observe a correlation between heritability estimates and factors relating 141 
to study makeup (Table S4; Fig. S1C-F). Since some of the results interpretation depends on lack 142 
of observed correlation, we explored the behavior of observed correlation vs power (Fig. S2A), 143 
standard errors (Fig. S2B) and the individual results (Fig. S2C and D) to identify where we can 144 
be reasonably robust in claiming lack of correlation with current datasets.  145 
In expanding on the number of pairwise comparisons in brain disorders, we observed 146 
widespread sharing across psychiatric disorders (Fig. 1 and S3) beyond those previously reported 147 
(17), but not among neurological disorders. Among the psychiatric disorders, schizophrenia 148 
showed significant genetic correlation with most of the psychiatric disorders, while MDD was 149 
positively (though not necessarily significantly) correlated with every other disorder tested. 150 
Further, schizophrenia, bipolar disorder, anxiety disorders, MDD and ADHD each showed a high 151 
degree of correlation to the four others (average rg=0.40; Table S5). Anorexia nervosa, 152 
obsessive-compulsive disorder (OCD) and schizophrenia also demonstrated significant sharing 153 
amongst themselves. On the other hand, the common variant risk of both ASD and Tourette 154 
Syndrome (TS) appear to be somewhat distinct from other psychiatric disorders, although with 155 
significant correlation between TS, OCD and MDD, as well as between ASD and schizophrenia. 156 
Post-traumatic stress disorder (PTSD) alone showed no significant correlation with any of the 157 
other psychiatric phenotypes (though some correlation to ADHD and MDD was observed, Fig. 158 
1). The modest power of the ASD, PTSD and TS meta-analyses, however, limits the strength of 159 
this conclusion (Fig. S2C).  160 
Neurological disorders revealed greater specificity, and a more limited extent of genetic 161 
correlation than the psychiatric disorders (Fig. 2 and S4, Table S5). Parkinson’s disease, 162 
Alzheimer’s disease, generalized epilepsy and multiple sclerosis showed little to no correlation 163 
with any other brain disorders. Focal epilepsy showed the highest degree of genetic correlation 164 
among the neurological disorders (average rg =0.46, excluding other epilepsy datasets), though 165 
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none were significant, reflecting the relatively modest power of the current focal epilepsy meta-166 
analysis (Fig. S2C). However, the modest heritability and the broad pattern of sharing observed 167 
for focal epilepsy may be consistent with considerable heterogeneity and potentially even 168 
diagnostic misclassification across a range of neurological conditions.  169 
In the cross-category correlation analysis, the overall pattern is consistent with limited 170 
sharing across the included neurological and psychiatric disorders (Fig. 3; average rg=0.03). The 171 
only significant cross-category correlations were with migraine, suggesting it may share some of 172 
its genetic architecture with psychiatric disorders; migraine-ADHD (rg=0.26, p=8.81 x 10-8), 173 
migraine-TS (rg=0.19, p=1.80 x 10-5), and migraine-MDD (rg=0.32, p=1.42 x 10-22 for all 174 
migraine, rg=0.23, p=5.23 x 10-5 for migraine without aura, rg=0.28, p=1.00 x 10-4 for migraine 175 
with aura). 176 
We observed several significant genetic correlations between the behavioral-cognitive or 177 
additional phenotypes and brain disorders (Fig. 4, Table S6). Results for cognitive traits were 178 
dichotomous among psychiatric phenotypes (Fig. S5A), with ADHD, anxiety disorders, MDD 179 
and Tourette Syndrome showing negative correlations to the cognitive measures, while anorexia 180 
nervosa, ASD, bipolar disorder and OCD showed positive correlations. Schizophrenia showed 181 
more mixed results, with significantly negative correlation to intelligence but positive correlation 182 
to years of education. Among neurological phenotypes (Fig. S5B), the correlations were all 183 
either negative or null, with Alzheimer’s disease, epilepsy, ICH, ischemic stroke, early-onset 184 
stroke and migraine showing significantly negative correlations. Correlations with bipolar 185 
disorder(24), Alzheimer’s disease and schizophrenia have been previously reported(28)).  186 
Among the personality measures, significant positive correlations were observed for 187 
neuroticism (anorexia nervosa, anxiety disorders, migraine, migraine without aura, MDD, OCD, 188 
schizophrenia and Tourette Syndrome; Fig. S6A), depressive symptoms (ADHD, anxiety 189 
disorder, bipolar disorder, MDD, and schizophrenia) and subjective well-being (anxiety disorder, 190 
bipolar disorder, MDD, as well as replicating the previously reported correlation between 191 
neuroticism with both MDD and schizophrenia(29)). For smoking-related measures, the only 192 
significant genetic correlations were to never/ever smoked (MDD: rg=0.33, p=3.10 x 10-11 and 193 
ADHD: rg=0.37, p=3.15 x 10-6).  194 
Among the additional phenotypes, the two diseases chosen as examples of disorders with 195 
well-defined etiologies had different results: Crohn’s disease, representing immunological 196 
pathophysiology, showed no correlation with any of the study phenotypes, while the phenotype 197 
representing vascular pathophysiology (coronary artery disease) showed significant correlation 198 
to MDD (rg=0.19, p=8.71 x 10-5) as well as the two stroke-related phenotypes (rg=0.69, p=2.47 x 199 
10-6 to ischemic stroke and rg=0.86, p=2.26 x 10-5 for early-onset stroke), suggesting shared 200 
genetic effects across these phenotype. Significant correlations were also observed for BMI, 201 
which was positively correlated with ADHD and MDD, and negatively correlated with anorexia 202 
nervosa (as previously reported with a different dataset(24)) and schizophrenia. 203 
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Our enrichment analysis (Fig. S7, Table S7 and S8) demonstrated novel significant 204 
heritability enrichments between central nervous system (CNS) and generalized epilepsy, MDD, 205 
TS, college attainment, intelligence, neuroticism, never/ever smoked); depressive symptoms and 206 
adrenal/pancreatic cells and tissues, as well as between immune system cells and multiple 207 
sclerosis. We also note with interest that the psychiatric disorders with large numbers of 208 
identified GWAS loci (bipolar disorder, MDD and schizophrenia) and the only cross-correlated 209 
neurological disorder with the same (migraine) all show enrichment to conserved regions, while 210 
the other neurological disorders with similar numbers of loci (MS and Alzheimer’s and 211 
Parkinson’s diseases) do not (Fig. S7A, B). Significant enrichment to conserved regions was also 212 
observed to neuroticism, intelligence and college attainment and to H3K9ac peaks for BMI. We 213 
also replicate the previously reported (CNS) enrichment for schizophrenia, bipolar disorder and 214 
years of education (here in a larger dataset compared to the original report, but with considerable 215 
sample overlap), and observe the previously reported enrichments for BMI (CNS), years of 216 
education (CNS), height (connective tissues and bone, cardiovascular system and other) and 217 
Crohn’s disease (hematopoietic cells) from the same datasets (Fig. S7C, D) (26).  218 
 219 
Discussion 220 
By integrating and analyzing the current genome-wide association summary statistic data 221 
from consortia of 25 brain disorders, we find that psychiatric disorders broadly share a 222 
considerable portion of their common variant genetic risk, especially across schizophrenia, 223 
MDD, bipolar disorder, anxiety disorder and ADHD, while neurological disorders are more 224 
genetically distinct. Across categories, psychiatric and neurologic disorders share relatively little 225 
of their common genetic risk, suggesting that multiple different and largely independently 226 
regulated etiological pathways may give rise to similar clinical manifestations (e.g., psychosis, 227 
which manifests in both schizophrenia(30) and Alzheimer’s disease(31)). Except for migraine, 228 
which appears to share some genetic architecture with psychiatric disorders, the existing clinical 229 
delineation between neurology and psychiatry is recapitulated at the level of common variant 230 
risk for the studied disorders.  231 
Given that the broad and continuous nature of psychiatric disorder spectra in particular 232 
has been clinically recognized for a long time(32-34) and that patients can, in small numbers, 233 
progress from one diagnosis to another(35), we evaluated to what extent diagnostic 234 
misclassification could explain the observed correlations. Genetic correlation could arise if, for 235 
example, substantial numbers of patients progress through multiple diagnoses over their lifetime, 236 
or if some specific diagnostic boundaries between phenotype pairs are particularly porous to 237 
misclassification; while it would be unlikely to observe large-scale misclassification of migraine 238 
as schizophrenia, for example, there may be more substantial misclassification between other 239 
pairs, consistent with the clinical controversies in classification. Previous work(36) suggests that 240 
substantial misclassification (on the order of 15-30%, depending on whether it is uni- or 241 
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bidirectional) is required to introduce high levels of genetic correlation. We sought to confirm 242 
and expand upon these estimates by performing large-scale simulations and calculating the 243 
resulting correlations across a variety of scenarios (Fig. S8, S9, Table S9 and Supplementary 244 
Text). First, we established that the observed heritability of the simulated misclassified traits 245 
behaves as expected (Fig. S8A), and that the effects on observed correlation (Fig. S8B and S8C) 246 
are in line with the estimates from family data(36). We further explored the effect of 247 
misclassification on observed rg given the correlation observed in real data. Reasonably low 248 
levels of misclassification or changes to the exact level of heritability appear unlikely to induce 249 
substantial changes in the estimated genetic correlation, though a lower observed heritability 250 
caused by substantial misclassification (Fig. S8A) will decrease the power to estimate the genetic 251 
overlap, as observed in the power analysis (Fig. S10). Further, such evidence of genetic overlap 252 
is unlikely to appear in the absence of underlying genetic correlation (Table S10), as it is 253 
apparent that a very high degree of misclassification (up to 79%) would be required to produce 254 
the observed correlations in the absence of any true genetic correlation. Therefore, the observed 255 
correlations suggest true sharing of a substantial fraction of the common variant genetic 256 
architecture among psychiatric disorders as well as between behavioral-cognitive measures and 257 
brain disorders.  258 
The high degree of genetic correlation among the psychiatric disorders adds further 259 
evidence that current clinical diagnostics do not reflect the underlying genetic etiology of these 260 
disorders, and that genetic risk factors for psychiatric disorders do not respect clinical diagnostic 261 
boundaries. This suggests an interconnected nature for their genetic etiology, in contrast to 262 
neurological disorders, and underscores the need to refine psychiatric diagnostics. This study 263 
may provide important ‘scaffolding’ to support a new research framework for investigating 264 
mental disorders, incorporating many levels of information to understand basic dimensions of 265 
brain function, such as through the National Institute of Mental Health’s RDoC initiative.  266 
The observed positive genetic correlations are consistent with a few different scenarios. 267 
For example, rg may reflect the existence of some portion of common genetic risk factors 268 
conferring equal risks to multiple disorders where other distinct additional factors contribute to 269 
the eventual clinical presentation. The presence of significant genetic correlation may also reflect 270 
the phenotypic overlap between any two disorders; for example, the sharing between 271 
schizophrenia and ADHD might reflect underlying difficulties in executive functioning, which 272 
are well-established in both disorders(37). Similarly, the sharing between anorexia nervosa, OCD 273 
and schizophrenia may reflect a shared mechanism underlying cognitive biases that extend from 274 
overvalued ideas to delusions. Another scenario is that a heritable intermediate trait confers risk 275 
to multiple outcomes, thereby giving rise to the genetic correlation, as the genetic influences on 276 
this trait will be shared for both outcomes (e.g., obesity as a risk factor for both type 2 diabetes 277 
and coronary artery disease), or that even the majority of common genetic effects are shared 278 
between a pair of traits, but each individual effect may confer different degrees of risk and lead 279 
to different aggregate genetic risk profiles. While a combination of these is likely, it will become 280 
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increasingly feasible to evaluate these overlaps at the locus level as more genome-wide 281 
significant loci are identified in the future. 282 
The low correlations observed across neurological disorders suggest that the current 283 
classification reflects relatively specific genetic etiologies, although the limited sample size for 284 
some of these disorders and lack of inclusion of disorders conceived as “circuit-based” in the 285 
literature, such as restless legs syndrome, sleep disorders and possibly essential tremor, 286 
constrains the generalizability of this conclusion. Generally, this analysis recapitulates the 287 
current understanding of the relatively distinct primary etiology underlying these disorders; 288 
degenerative disorders (such as Alzheimer’s and Parkinson’s diseases) would not be expected a 289 
priori to share their polygenic risk profiles with a neuro-immunological disorder (like multiple 290 
sclerosis) or neurovascular disorder (like ischemic stroke). Similarly, we see limited evidence for 291 
the reported co-morbidity between migraine with aura and ischemic stroke(38) (rg=0.29, 292 
p=0.099); however, the standard errors of this comparison are too high to draw strong 293 
conclusions. At the disorder subtype level, migraine with and without aura (rg=0.48, p=1.79 x 10-294 
5) shows substantial genetic correlation, while focal and generalized epilepsy (rg=0.16, p=0.388) 295 
show much less.  296 
The few significant correlations across neurology and psychiatry, namely between 297 
migraine and ADHD, MDD and TS, suggest modest shared etiological overlap across the 298 
neurology/psychiatry distinction. The co-morbidity of migraine with MDD, Tourette Syndrome 299 
and ADHD has been previously reported in epidemiological studies (39-42), while in contrast, 300 
the previously reported co-morbidity between migraine and bipolar disorder seen in 301 
epidemiological studies (43) was not reflected in our estimate of genetic correlation (rg=-0.03, 302 
p=0.406).   303 
Several phenotypes show only very low-level correlations with any of the other disorders 304 
and phenotypes studied here, despite large sample size and robust evidence for heritability, 305 
suggesting their common variant genetic risk may largely be unique. Alzheimer’s disease, 306 
Parkinson’s disease, and multiple sclerosis show extremely limited sharing with the other 307 
phenotypes and with each other. Neuroinflammation has been implicated in the pathophysiology 308 
of each of these conditions(44-46), as it has for migraine(47) and many psychiatric conditions, 309 
including schizophrenia(48), but no considerable shared heritability was observed with either of 310 
those conditions nor with Crohn’s disease, nor did we observe enrichment for immune-related 311 
tissues in the functional partitioning (Fig. S7) as we did for Crohn’s disease. While this 312 
observation does not preclude shared neuroinflammatory mechanisms in these disorders, it does 313 
suggest that on a large scale, common variant genetic influences on these inflammatory 314 
mechanisms are not shared between these disorders. Further, we only observed significant 315 
enrichment of heritability for immunological cells and tissues in multiple sclerosis, showing that 316 
inflammation-specific regulatory marks in the genome do not show overall enrichment for 317 
common variant risk for either Alzheimer’s or Parkinson’s diseases (though this does not 318 
preclude the effects of specific, non-polygenic neuroinflammatory mechanisms(49)). Among 319 
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psychiatric disorders, ASD and TS showed a similar absence of correlation with other disorders, 320 
although this could reflect small sample sizes. 321 
Analysis of the Big Five personality measures suggest that the current sample sizes for 322 
personality data are beginning to be sufficiently large for correlation testing; neuroticism, which 323 
has by far the largest sample size, shows several significant correlations. Most significant of 324 
these was to MDD (rg=0.737, p=5.04 x 10-96), providing further evidence for the link between 325 
these phenotypes, reported previously with polygenic risk scores(50) and twin studies(51, 52); 326 
others included schizophrenia, anxiety disorders, migraine, migraine without aura, and OCD 327 
(Table S6). Further, the observation of strong correlation between MDD and anxiety disorders 328 
together with their remarkably strong and similar patterns of correlation between each of these 329 
disorders and the dimensional measures of depressive symptoms, subjective well-being, and 330 
neuroticism suggests that they all tag a fundamentally similar underlying etiology. The novel 331 
significant correlation between coronary artery disease and MDD supports the long-standing 332 
epidemiological observation of a link between MDD and CAD(53), while the observed 333 
correlation between ADHD and smoking initiation (rg=0.374, p=3.15 x 10-6) is consistent with 334 
the epidemiological evidence of overlap(54) and findings from twin studies(55), supporting the 335 
existing hypothesis that impulsivity inherent in ADHD may drive smoking initiation and 336 
potentially dependence (though other explanations, such as reward system dysfunction would fit 337 
as well). 338 
For the neurological disorders, five (Alzheimer’s disease, intracerebral hemorrhage, 339 
ischemic and early-onset stroke, and migraine) showed significant negative genetic correlation to 340 
the cognitive measures, while a further two (epilepsy and focal epilepsy) showed moderate 341 
negative genetic correlation (Fig. S5). For Alzheimer’s disease, poor cognitive performance in 342 
early life has been linked to increased risk for developing the disorder in later life(56), but to our 343 
knowledge no such connection has been reported for the other phenotypes. ADHD, anxiety 344 
disorders and MDD show a significant negative correlation to cognitive and education attainment 345 
measures, while the remaining five of the eight psychiatric disorders (anorexia nervosa, ASD, 346 
bipolar disorder, OCD, and schizophrenia) showed significant positive genetic correlation with 347 
one or more cognitive measures. These results strongly suggest the existence of a link between 348 
cognitive performance already in early life and the genetic risk for both psychiatric and 349 
neurological brain disorders. The basis of the genetic correlations between education, cognition 350 
and brain disorders may have a variety of root causes including indexing performance 351 
differences based on behavioral dysregulation (e.g., ADHD relating to attentional problems 352 
during cognitive tests) or may reflect ascertainment biases in certain disorders conditional on 353 
impaired cognition (e.g., individuals with lower cognitive reserve being more rapidly identified 354 
for Alzheimer’s disease).  355 
BMI shows significant positive genetic correlation to ADHD, consistent with a meta-356 
analysis linking ADHD to obesity(57), and negative genetic correlation with anorexia nervosa, 357 
OCD and schizophrenia. These results are consistent with the evidence for enrichment of BMI 358 
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heritability in CNS tissues(26) and that many reported signals suggest neuronal involvement(58); 359 
this may also provide a partial genetic explanation for lower BMI in anorexia nervosa patients 360 
even after recovery(59). Given that no strong correlations were observed between BMI and any 361 
of the neurological phenotypes, it is possible to hypothesize that BMI’s brain-specific genetic 362 
architecture is more closely related to behavioral phenotypes. Ischemic stroke and BMI show 363 
surprisingly little genetic correlation in this analysis (rg=0.07, p=0.26), suggesting that although 364 
BMI is a strong risk factor for stroke(60), there is little evidence for shared common genetic 365 
effects. These analyses also suggest that the reported reduced rates of cardiovascular disease in 366 
individuals with histories of anorexia nervosa (61, 62) are due to BMI-related effects; with the 367 
limited evidence of genetic correlation of anorexia nervosa with intracerebral hemorrhage, 368 
ischemic stroke, early-onset stroke and coronary artery disease, these results suggest that any 369 
lower cardiovascular mortality is more likely due to direct BMI-related effects rather than  370 
shared common genetic risk variants.  371 
It is broadly apparent from the results presented here that the current clinical boundaries 372 
for the studied psychiatric phenotypes do not reflect distinct underlying pathogenic processes 373 
based on the genetic evidence, while in contrast, the studied neurological disorders show much 374 
greater genetic specificity. Although it is important to emphasize that while some disorders are 375 
under-represented here (e.g. personality disorders in psychiatry and circuit-based disorders [such 376 
as restless leg syndrome] in neurology), these results clearly demonstrate the limited evidence for 377 
widespread common genetic risk sharing between psychiatric and neurological disorders, while  378 
providing strong evidence for links between them and behavioral-cognitive measures. We 379 
highlight the need for some degree of restructuring of psychiatric nosology and that genetically 380 
informed analyses may provide a good basis for such activities, consistent with the historical 381 
knowledge from twin and family-based results. Further elucidation of individual disorders and 382 
their genetic overlap, especially as distinct loci map onto a subset of disorders and etiological 383 
processes, may form the basis for either defining new clinical phenotypes or support a move to a 384 
more continuous view of psychiatric phenotypes. Further study is needed to evaluate whether 385 
overlapping genetic contributions to psychiatric pathology may influence optimal treatment 386 
choices. Ultimately, such developments give hope to reducing diagnostic heterogeneity and 387 
eventually improving the diagnostics and treatment of psychiatric disorders.  388 
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 572 
Data sources 573 
Disorder or phenotype – Consortium or dataset identifier – web address: 574 
Psychiatric disorders  575 
ADHD – PGC-ADD2 - http://www.med.unc.edu/pgc/results-and-downloads 576 
Anorexia nervosa(63) – PGC-ED - http://www.med.unc.edu/pgc/results-and-downloads 577 
Anxiety disorder(64) – ANGST - http://www.med.unc.edu/pgc/results-and-downloads 578 
Autism spectrum disorders(65) – PGC-AUT - http://www.med.unc.edu/pgc/results-and-downloads 579 
Bipolar disorder – PGC-BIP2 - http://www.med.unc.edu/pgc/results-and-downloads (soon) 580 
Major depressive disorder – PGC-MDD2 - http://www.med.unc.edu/pgc/results-and-downloads (soon) 581 
OCD – PGC-OCDTS - http://www.med.unc.edu/pgc/results-and-downloads  582 
PTSD – PGC-PTSD - http://www.med.unc.edu/pgc/results-and-downloads  583 
Schizophrenia(22) – PGC-SCZ2 – http://www.med.unc.edu/pgc/results-and-downloads 584 
Tourette Syndrome – TSAIGC – http://www.med.unc.edu/pgc/results-and-downloads 585 
 586 
Neurological disorders  587 
Alzheimer's disease(18) – IGAP - http://www.pasteur-lille.fr/en/recherche/u744/igap 588 
Epilepsy and subtypes, focal and generalized(66) – ILAE – http://www.epigad.org/page/show/gwas_index 589 
Intracerebral hemorrhage(67) – ISGC - http://www.strokegenetics.com/ 590 
Ischemic stroke and subtypes (cardioembolic, early-onset, small-vessel and large-vessel)(68) – METASTROKE 591 
dataset of the ISGC – http://www.strokegenetics.com/ 592 
Migraine and subtypes, migraine with and without aura – IHGC – www.headachegenetics.org 593 
Multiple sclerosis(69) – IMSGC - http://eaglep.case.edu/imsgc_web 594 
Parkinson's disease(21) – IPDGC – www.pdgene.org 595 
 596 
Behavioral-cognitive phenotypes 597 
College attainment, years of education(70) – SSGAC – http://www.thessgac.org/data 598 
Childhood cognitive performance(71) – SSGAC – http://www.thessgac.org/data 599 
Extraversion, agreeableness, conscientiousness and openness (27) – GPC – http://www.tweelingenregister.org/GPC/ 600 
IQ(72) – CTG - http://ctg.cncr.nl/software/summary_statistics  601 
Neuroticism, depressive symptoms and subjective well-being (73) – SSGAC - http://www.thessgac.org/data 602 
Never/ever smoked, cigarettes per day(74) - TAG - http://www.med.unc.edu/pgc/results-and-downloads 603 
 604 
Additional phenotypes  605 
BMI(58) – GIANT – https://www.broadinstitute.org/collaboration/giant 606 
Height(75) – GIANT – https://www.broadinstitute.org/collaboration/giant 607 
Crohn’s disease(76) – IIBDGC - http://www.ibdgenetics.org/downloads.html 608 
Coronary artery disease(77) – Cardiogram – http://www.cardiogramplusc4d.org/downloads/  609 
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Figure 1. Genetic correlation matrix across psychiatric phenotypes.  610 
 611 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 612 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 613 
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; 614 
MDD – major depressive disorder; OCD – obsessive-compulsive disorder; PTSD – post-traumatic stress disorder. 615 
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Figure 2. Genetic correlation matrix across neurological phenotypes.  616 
 617 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 618 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 619 
after Bonferroni correction.  Some phenotypes have substantial overlaps (see Table 1), e.g. all cases of generalized 620 
epilepsy are also cases of epilepsy. Asterisks indicate significant genetic correlation after multiple testing 621 
correction. ICH – intracerebral hemorrhage. 622 
  623 
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Figure 3. Genetic correlation matrix across neurological and psychiatric phenotypes.  624 
 625 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 626 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 627 
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; ICH 628 
– intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-compulsive disorder; PTSD – 629 
post-traumatic stress disorder.  630 
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Figure 4. Genetic correlation matrix across brain disorders and behavioral-cognitive phenotypes.  631 
 632 
Color of each box indicates the magnitude of the correlation, while size of the boxes indicates its significance, with 633 
significant correlations filling each box completely. Asterisks indicate genetic correlations which are significant 634 
after Bonferroni correction. ADHD – attention deficit hyperactivity disorder; ASD – autism spectrum disorder; ICH 635 
– intracerebral hemorrhage; MDD – major depressive disorder; OCD – obsessive-compulsive disorder; PTSD – 636 
post-traumatic stress disorder; BMI –body-mass index.  637 
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Table 1. Brain disorder phenotypes used in the Brainstorm project. Indented phenotypes are part of a larger whole, 638 
e.g. the epilepsy study consists of the joint analysis of focal epilepsy and generalized epilepsy. Numbers in gray 639 
denote a sample set which is non-unique, e.g. cardioembolic stroke samples are a subset of ischemic stroke samples. 640 
ADHD – attention deficit hyperactivity disorder; OCD – obsessive-compulsive disorder. ‘Anxiety disorders’ refers 641 
to a meta-analysis of five subtypes (generalized anxiety disorder, panic disorder, social phobia, agoraphobia and 642 
specific phobias). Source details are listed under Data Sources and the references in Table S1. 643 
 644 
 645 
  646 
Psychiatric disorders Neurological disorders
Disorder Source Cases Controls Disorder Source Cases Controls
ADHD PGC-ADD2 12,645 84,435 Alzheimer's disease IGAP 17,008 37,154
Anorexia nervosa PGC-ED 3,495 11,105 Epilepsy ILAE 7,779 20,439
Anxiety disorders ANGST 5,761 11,765    Focal epilepsy " 4,601 17,985
Autism spectrum disorder PGC-AUT 6,197 7,377    Generalized epilepsy " 2,525 16,244
Bipolar disorder PGC-BIP2 20,352 31,358 Intracerebral hemorrhage ISGC 1,545 1,481
Major depressive disorder PGC-MDD2 16,823 25,632 Ischemic stroke METASTROKE 10,307 19,326
OCD PGC-OCDTS 2,936 7,279     Cardioembolic stroke " 1,859 17,708
PTSD PGC-PTSD 2,424 7,113     Early-onset stroke " 3,274 11,012
Schizophrenia PGC-SCZ2 33,640 43,456     Large-vessel disease " 1,817 17,708
Tourette Syndrome PGC-OCDTS 4,220 8,994     Small-vessel disease " 1,349 17,708
Migraine IHGC 59,673 316,078
   Migraine with aura " 6,332 142,817
   Migraine without aura " 8,348 136,758
Multiple sclerosis IMSGC 5,545 12,153
Parkinson's disease IPDGC 5,333 12,019
Total psychiatric 108,493 238,514 Total neurologic 107,190 418,650
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Table 2. Behavioral-cognitive and additional phenotypes used in the study. Numbers in gray denote overlapping 647 
study sets, e.g. samples in the college attainment analysis are a subset of those in the analysis for years of education. 648 
(d) – dichotomous phenotype, (q) – quantitative phenotype. BMI – body-mass index. Source details are listed under 649 
Data Sources, while references are listed in Table S2.  650 
  651 
  652 
Phenotype Source Samples
Behavioral-cognitive phenotypes
Cognitive
   Years of education (q) SSGAC 293,723
   College attainment (d) " 120,917
   Cognitive performance (q) " 17,989
   Intelligence (d) CTG 78,308
Personality measures
   Subjective well-being SSGAC 298,420
   Depressive symptoms " 161,460
   Neuroticism (q) " 170,911
   Extraversion (q) GPC 63,030
   Agreeableness (q) " 17,375
   Conscientiousness (q) " 17,375
   Openness (q) " 17,375
Smoking-related
   Never/ever smoked (d) TAG 74,035
   Cigarettes per day (q) TAG 38,617
Additional phenotypes
   BMI (q) GIANT 339,224
   Height (q) " 253,288
   Coronary artery disease (d) Cardiogram 86,995
   Crohn's disease (d) IIBDGC 20,883
Total 1,124,048
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